Literature DB >> 28547652

Histone H3 K27M mutations in adult cerebellar high-grade gliomas.

Satoshi Nakata1,2, Sumihito Nobusawa3, Tatsuya Yamazaki3, Tadashi Osawa4, Keishi Horiguchi4, Yasuhiro Hashiba5, Hiroyuki Yaoita6, Nozomi Matsumura3, Hayato Ikota3, Junko Hirato3,7, Yuhei Yoshimoto4, Hideaki Yokoo3.   

Abstract

Adult cerebellar high-grade gliomas (HGG) are rare and their molecular basis has not been fully elucidated. Although a diffuse midline glioma H3 K27M-mutant, a recently characterized variant of HGG, was reported to occasionally occur in the cerebellum, adult cases were rarely tested for this mutation; only five mutant cases have been reported to date. It currently remains unknown whether H3 K27M-mutant cerebellar gliomas share common histological features or have a uniformly dismal prognosis. In the present study, we assessed the prevalence of histone H3 K27M mutations in ten adult cerebellar HGG, identifying two H3F3A-mutant cases. One case was a 70-year-old female with a cystic lesion. Histologically, the tumor was considered to be glioblastoma; however, a part of the tumor exhibiting low proliferative activity appeared to be consistent with long-standing H3 K27M-mutant tumors in the literature. Another case was a 69-year-old male. The tumor showed a distinct circumscribed histology with minimal astrocytic differentiation, suggesting a nosological issue in the diagnosis of diffuse midline glioma. More cerebellar tumors need to be tested for H3 K27M mutations to clarify the clinical and histopathological spectra of this tumor.

Entities:  

Keywords:  Cerebellum; H3F3A; HIST1H3B; High-grade glioma; Histone H3

Mesh:

Substances:

Year:  2017        PMID: 28547652     DOI: 10.1007/s10014-017-0288-6

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  8 in total

1.  Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.

Authors:  Michael Zhang; Richard Li; Erqi L Pollom; Arya Amini; Savita Dandapani; Gordon Li
Journal:  J Clin Neurosci       Date:  2020-11-06       Impact factor: 1.961

2.  Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.

Authors:  Luc Bauchet; Jacques Guyotat; Thiébaud Picart; David Meyronet; Johan Pallud; Chloé Dumot; Philippe Metellus; Sonia Zouaoui; Moncef Berhouma; François Ducray
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-05       Impact factor: 4.553

3.  Characteristics of cerebellar glioblastomas in adults.

Authors:  Thiébaud Picart; Marc Barritault; Julien Berthillier; David Meyronet; Alexandre Vasiljevic; Didier Frappaz; Jérôme Honnorat; Emmanuel Jouanneau; Delphine Poncet; François Ducray; Jacques Guyotat
Journal:  J Neurooncol       Date:  2017-12-01       Impact factor: 4.130

4.  Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases.

Authors:  Linmao Zheng; Jing Gong; Tianping Yu; Yan Zou; Mengni Zhang; Ling Nie; Xueqin Chen; Qiang Yue; Yanhui Liu; Qing Mao; Qiao Zhou; Ni Chen
Journal:  Am J Surg Pathol       Date:  2022-04-13       Impact factor: 6.298

5.  Cerebellar high-grade glioma with H3 K27M mutation: illustrative case.

Authors:  Mikiko Takahashi; Yusuke Tomita; Shoko Merrit Yamada; Kazuto Yamazaki; Hideaki Yokoo; Tatsuya Aso; Masashi Kawamoto
Journal:  J Neurosurg Case Lessons       Date:  2021-02-08

6.  H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

Authors:  Bette K Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  Clin Neuropathol       Date:  2018 Mar/Apr       Impact factor: 1.368

7.  MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells.

Authors:  Shoshana Paglin; Amos Toren; Michal Yalon; Ziv Versano; Eitan Shany; Shany Freedman; Liron Tuval-Kochen; Moshe Leitner
Journal:  Oncotarget       Date:  2018-06-08

8.  Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.

Authors:  Annekathrin Reinhardt; Damian Stichel; Daniel Schrimpf; Christian Koelsche; Annika K Wefers; Azadeh Ebrahimi; Philipp Sievers; Kristin Huang; M Belén Casalini; Francisco Fernández-Klett; Abigail Suwala; Michael Weller; Dorothee Gramatzki; Joerg Felsberg; Guido Reifenberger; Albert Becker; Volkmar H Hans; Marco Prinz; Ori Staszewski; Till Acker; Hildegard Dohmen; Christian Hartmann; Werner Paulus; Katharina Heß; Benjamin Brokinkel; Jens Schittenhelm; Rolf Buslei; Martina Deckert; Christian Mawrin; Ekkehard Hewer; Ute Pohl; Zane Jaunmuktane; Sebastian Brandner; Andreas Unterberg; Daniel Hänggi; Michael Platten; Stefan M Pfister; Wolfgang Wick; Christel Herold-Mende; Andrey Korshunov; David E Reuss; Felix Sahm; David T W Jones; David Capper; Andreas von Deimling
Journal:  Acta Neuropathol Commun       Date:  2019-10-28       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.